PT-141 10 MG

PT-141, also known as Bremelanotide, is a synthetic cyclic heptapeptide research compound studied in laboratory settings as an agonist of the melanocortin receptor family. As a synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH), PT-141 is examined for its interaction with melanocortin signaling research models. Each vial from Central Peptides contains 10 mg of high-purity PT-141, third-party verified and supplied with a batch-specific Certificate of Analysis (COA) for research use only. As one of the most studied melanocortin peptides, PT-141 remains a frequently requested compound among Canadian laboratories.

PT-141 Research Applications

PT-141 is a cyclic heptapeptide — a chain of seven amino acids arranged in a closed ring structure — derived from the melanocortin peptide family. Structurally, it is closely related to Melanotan II (MT-2): the two share the same cyclic core, but PT-141 carries a C-terminal carboxyl group where MT-2 has a C-terminal amide. This structural distinction makes the two compounds useful for comparative melanocortin research.

In controlled laboratory environments, researchers study PT-141 for its activity as an agonist at melanocortin receptors, including MC3R and MC4R. Research focuses on receptor binding, central nervous system signaling models, and comparative studies with other melanocortin analogs such as Melanotan II.

Common research areas where PT-141 is examined include:

• Melanocortin receptor (MC3R, MC4R) binding and activation research
• Central nervous system signaling pathway models
• Comparative research with Melanotan II and other melanocortin analogs
• Neuropeptide and receptor-ligand interaction studies

Purity and Quality Verification

Every batch of PT-141 sold by Central Peptides is manufactured under controlled synthesis and purification processes to ensure stability, consistency, and structural integrity for scientific research applications. Our compounds are independently tested and verified at 99% purity through High-Performance Liquid Chromatography (HPLC) and mass spectrometry.

Each order includes access to a batch-specific Certificate of Analysis, allowing researchers to verify identity, purity percentage, and testing details before use. This batch-level traceability is part of our commitment to transparency and quality control across our full research catalog. Researchers who require documented purity standards for their work can review the COA before and after purchase, ensuring every vial meets the same verified specification.

Product Specifications

• Compound: PT-141 (Bremelanotide)
• Structure: Cyclic heptapeptide, alpha-MSH analog
• Quantity: 10 mg per vial
• Purity: 99% (HPLC verified)
• Physical form: Lyophilized powder
• Lab testing: In-house HPLC and mass spectrometry
• COA: Batch-specific, available for every order
• View COA here: Lab Results | CentralPeptides.ca

Storage and Handling

PT-141 is supplied as a lyophilized (freeze-dried) powder for maximum stability during shipping and storage. Lyophilization removes moisture from the compound, which helps preserve its structural integrity over time and allows it to remain stable during transit. For long-term integrity, store the lyophilized compound sealed in a cool, dry environment away from light.

Once reconstituted for research, PT-141 is soluble in bacteriostatic water and should be kept refrigerated at 2-8°C. To preserve compound integrity, aliquot the reconstituted material to avoid repeated freeze-thaw cycles, and use within an appropriate window to maintain consistency in research results.

Shipping Across Canada

Central Peptides ships PT-141 and all research compounds across Canada in discreet, temperature-conscious packaging. Orders are typically processed within 24 hours and delivered within 3 to 5 business days. Free delivery is available on qualifying orders over the threshold listed at checkout.

As a Canadian-based supplier, we offer domestic fulfillment, which means faster delivery times and fewer customs complications compared to ordering from international sources. Every shipment is packaged to protect the compound during transit and to maintain privacy.

Important Notice

• This product is intended for laboratory research and scientific purposes only.
• It is not approved by Health Canada, the FDA, or any other regulatory authority for human or veterinary use in this research-grade form.
• This product is not intended to diagnose, treat, cure, or prevent any disease.
• By purchasing this product, customers acknowledge that it is strictly for research use only.

Buyers are responsible for conducting their own research and understanding the characteristics and intended use of this product prior to purchase.

For additional reference data on this compound, see PubChem: PubChem